ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,191Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 98

$9,486 Total Retail Price of All Prescriptions

Rank: 91 out of 98

195 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 195 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

12% of this provider’s 195 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 10,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$1 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

57 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
OMEPRAZOLE 595 571 1 6
LISINOPRIL 509 497 2 3
FUROSEMIDE 501 501 3 4
WARFARIN SODIUM 471 471 4 1
METOPROLOL SUCCINATE 453 428 5 16
DONEPEZIL HCL 424 422 6 12
SIMVASTATIN 414 389 7 2
LEVOTHYROXINE SODIUM 375 362 8 5
NAMENDA 325 313 9 18
AMLODIPINE BESYLATE 238 225 10 7
METOPROLOL TARTRATE 235 235 11 8
MIRTAZAPINE 207 207 12 11
CITALOPRAM HBR 197 163 13 10
PREDNISONE 171 171 14 31
VENLAFAXINE HCL ER 162 150 15 65
GABAPENTIN 139 120 16 13
POTASSIUM CHLORIDE 136 136 17 21
DIVALPROEX SODIUM 130 117 18 22
QUETIAPINE FUMARATE 124 124 19 23
ESCITALOPRAM OXALATE 124 124 19 60
ISOSORBIDE MONONITRATE ER 119 119 21 36
DIGOXIN 112 112 22 40
TRAZODONE HCL 109 100 23 9
ATENOLOL 109 97 23 14
SERTRALINE HCL 106 106 25 19
LIDODERM 103 103 26 29
SPIRIVA 103 103 26 46
DILTIAZEM ER 102 102 28 235
RISPERIDONE 96 96 29 27
ALENDRONATE SODIUM 92 92 30 30
HYDROCODONE-ACETAMINOPHEN 91 90 S3 31 39
FINASTERIDE 88 88 32 49
GLIPIZIDE ER 88 88 32 121
ATORVASTATIN CALCIUM 87 87 34 20
TAMSULOSIN HCL 83 83 35 25
RANITIDINE HCL 78 78 36 35
ALLOPURINOL 73 73 37 43
HYDROCHLOROTHIAZIDE 72 72 38 17
METFORMIN HCL ER 71 71 39 139
PANTOPRAZOLE SODIUM 69 61 40 42
ADVAIR DISKUS 69 69 40 32
CELEBREX 65 57 42 119
METFORMIN HCL 63 63 43 15
OLANZAPINE 62 27 44 24
LYRICA 60 60 45 133
CRESTOR 59 47 46 51
CLOPIDOGREL 59 59 46 50
LANTUS 56 56 48 28
ABILIFY 56 56 48 66
LATANOPROST 52 52 50 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.